These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5714064)

  • 1. Results obtained in comparative radiographie, clinical and clinical-chemical studies in iocetamic acid (DRC 1201) and iopanoic acid.
    Hekster RE
    Radiol Clin Biol; 1968; 37(6):338-52. PubMed ID: 5714064
    [No Abstract]   [Full Text] [Related]  

  • 2. [The uricosuric action of contrast media used for the opacification of bile ducts (apropos of 27 cases)].
    Billis A; Dimopoulos C; Giamarellou H; Zoumbouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daïcos G
    Ann Med Interne (Paris); 1973 Dec; 124(12):853-62. PubMed ID: 4598722
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney repercussions of bile duct contrast media administration].
    Billis A; Dimopoulos C; Giamarellou H; Zoubouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daikos G
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):447-50. PubMed ID: 4804417
    [No Abstract]   [Full Text] [Related]  

  • 5. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity.
    Mudge GH
    N Engl J Med; 1971 Apr; 284(17):929-33. PubMed ID: 5551801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of three oral cholecystographic agents on laboratory data. Clinical chemical determinations and urinary tests (author's transl)].
    Kasezawa N; Tazawa R; Urushibata S; Kobayashi M
    Rinsho Byori; 1974 Jun; 22(6):440-4. PubMed ID: 4472714
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical trial of oral cholecystographic agents: telepaque, sodium oragrafin and calcium oragrafin.
    Tishler JM; Gold R
    J Can Assoc Radiol; 1969 Jun; 20(2):102-5. PubMed ID: 5793435
    [No Abstract]   [Full Text] [Related]  

  • 9. Uricosuria and x-ray contrast agents.
    Kelley WN
    N Engl J Med; 1971 Apr; 284(17):975-6. PubMed ID: 5573284
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical review 129: Oral cholecystographic agents and the thyroid.
    Braga M; Cooper DS
    J Clin Endocrinol Metab; 2001 May; 86(5):1853-60. PubMed ID: 11344170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nephrotoxicity caused by combined cholecystography? (Animal experiment).
    Bor K; Elek S; Elekes I; Polgari I; Csakany G
    Rays; 1985; 10(3):61-5. PubMed ID: 3843670
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative trial of three oral cholecystographic contrast media--iocetamic acid, iopanoic acid and sodium ipodate.
    Cargill A; Hately W
    Br J Radiol; 1981 Jan; 54(637):79-80. PubMed ID: 6449974
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute thrombocytopenia following oral cholecystography with iopanoic acid.
    Curradi F; Abbritti G; Agnelli G
    Clin Toxicol; 1981 Feb; 18(2):221-4. PubMed ID: 7226734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral cholecystopaques: iopronic acid vs. iopanoic acid.
    Amberg JR; Goldberger LA; Bates M
    Radiology; 1980 Jan; 134(1):31-2. PubMed ID: 6985742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacology of oral cholecystography].
    Gaón D
    Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405
    [No Abstract]   [Full Text] [Related]  

  • 17. Brief recordings. Acute renal failure after the administration of iopanoic acid as a cholecystographic agent.
    Canales CO; Smith GH; Robinson JC; Remmers AR; Sarles HE
    N Engl J Med; 1969 Jul; 281(2):89-91. PubMed ID: 5784785
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the diminution of thyroid iodine uptake after administration of an iodized contrast medium].
    Neborak SL; Alvarez AS; Cordero Funes J; Estevez M; Pahissa Campa J; De la Balze FA
    Rev Fr Endocrinol Clin; 1969; 10(6):463-70. PubMed ID: 5377027
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of three cholecystographic agents. A double-blind study with and without a prior fatty meal.
    Stanley RJ; Melson GL; Cubillo E; Hesker AE
    Radiology; 1974 Sep; 112(3):513-7. PubMed ID: 4602063
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical value of the four-day test of Salzman in the diagnosis of gallstones and its hazards].
    Taccari A; Ghergo GF; Menghini G
    Gastroenterologia; 1966; 105(1):35-44. PubMed ID: 5905803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.